Delivery Order SPE2DB22D1017-SPE2DB24FG0MF

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $12,754.00 to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award was issued by the Defense Logistics Agency (DLA) and is a Delivery Order contract for Atovaquone-Proguanil 250-100 100s, a prescription medication. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price contract. This award is likely part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $73,404 for the supply of Atovaquone-Proguanil 250-100 100s medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Atovaquone-Proguanil 250-100 mg tablets. The contract, valued at $25,807.93, is a firm-fixed-price delivery order with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $2,927.14 for the supply of 4,566,488,958 units of atovaquone-proguanil 250-100 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 20, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,268.54, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 6, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award is a delivery order with a firm fixed price valued at $14,414.31 that was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 4565826799 ATOVAQUONE-PROGUANIL 250-100 100S, a prescription medication. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S tablets. The contract has a total ceiling value of $1,834.36 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,912,417 units of Atovaquone-Proguanil 250-100mg tablets. The contract has a firm-fixed price of $4,079.80 and a completion date of September 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of atovaquone-proguanil 250-100 100s medication. The $2,943.11 firm fixed-price delivery order has a completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,766.96 firm fixed-price delivery order is for the supply of 4,566,847,770 units of Atovaquone-Proguanil 250-100 mg tablets, a medication used for the prevention and treatment of malaria. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG0MF
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,593.09, is for the delivery of the pharmaceutical product Atovaquone-Proguanil 250-100 100s.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current $1,593.09 award is not designated as a set-aside contract.

Generated 9/30/24, 12:18 PM